Highlights
AMEX: ATNM       Actinium Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
0.206   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):5,544,447
4 Weeks Range:0.174 - 0.22
4 Weeks Price Volatility (%):
93.64%
52 Weeks Range:0.157 - 0.41
52 Weeks Price Volatility (%):
50.24%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used in myeloconditioning for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

1929  3744  366  2912 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 JCP 0.1820.00 
 AVP 5.60-0.05 
 GE 6.495-0.285 
 ADAP 10.681+5.821 
 PHIO 4.009+1.769 
 PRTY 1.39+0.37 
 AABA 19.630.00 
 TGE 22.39+0.81 
 NCLH 15.325-0.745 
 SQQQ 9.845+0.015 
Partners & Brokers